Sofie Van Binnebeek

Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

Sofie Van Binnebeek, B Vanbilloen, Kristof Baete et al. · European Radiology · 2015 · 97 citations

Positron Emission Tomography, 111In-pentetreotide Spect, Medicine +9

Inflammation-Based Index and ⁶⁸Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with ⁹⁰Y-DOTATOC

Elin Pauwels, Sofie Van Binnebeek, Vincent Vandecaveye et al. · Journal of Nuclear Medicine · 2019 · 43 citations · Full text

Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy

Sofie Van Binnebeek, Kristof Baete, B Vanbilloen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 30 citations · Full text

Dosimetry-based Activity Reduction, Renal Function, Medicine +8

Response Assessment of Hormonal Therapy in Prostate Cancer by [11C] Choline PET/CT

A. De Waele, Sofie Van Binnebeek, Felix M. Mottaghy · Clinical Nuclear Medicine · 2010 · 14 citations

Positron Emission Tomography, Urology, Medical Imaging +15

Significant impact of transient deterioration of renal function on dosimetry in PRRT

Sofie Van Binnebeek, Kristof Baete, Christelle Terwinghe et al. · Annals of Nuclear Medicine · 2012 · 14 citations

Urology, Renal Function, Significant Impact +6